<DOC>
	<DOCNO>NCT00595764</DOCNO>
	<brief_summary>The major goal determine whether add cognitive behavioral therapy physician management increase efficacy buprenorphine/naloxone treatment office-based primary care setting .</brief_summary>
	<brief_title>Counseling Primary Care Office-based Buprenorphine</brief_title>
	<detailed_description>To evaluate need drug counseling aim reduce illicit drug use increase buprenorphine/naloxone adherence , propose study compare manual-guided Physician Management ( PM ) PM combine on-site manual-guided Cognitive Behavioral Therapy ( CBT ) 24 week randomize clinical trial buprenorphine/naloxone heterogeneous population opioid dependent patient ( N=140 ) primary care clinic . PM , consistent federal regulation , design reflect usual care primary care physician include referral ancillary service . CBT provide skilled psychologist weekly session first 12 week focus reduce illicit drug use increase buprenorphine/naloxone adherence . The study test hypothesis addition CBT PM lead decrease illicit drug use , durable effect counsel discontinue , improve buprenorphine/naloxone adherence demonstrate incremental cost-effectiveness patient receive buprenorphine/naloxone maintenance primary care . Primary outcome measure include reduction illicit opioid use abstinence achievement , assess weekly urine toxicology test self report . Secondary outcome measure include retention treatment , reduction cocaine use HIV risk , decrease criminal activity improve health employment status . Utilization cost service , spillover effect PCC , patient staff perception benefit problem associate primary care agonist maintenance treatment also evaluate . The result study help define role professional evidence-based drug counsel expand access treatment buprenorphine/naloxone .</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>opioid dependence current dependence alcohol , cocaine , benzodiazepines sedative current suicide homicide risk current psychotic disorder untreated major depression inability read understand English lifethreatening unstable medical problem</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Buprenorphine</keyword>
	<keyword>Buprenorphine/naloxone</keyword>
	<keyword>Counseling</keyword>
	<keyword>Primary care</keyword>
</DOC>